Medinol/Gore
This article was originally published in The Gray Sheet
Executive Summary
NIRTOP randomized study of 305 patients at 15 international centers demonstrates a 6.3% restenosis rate for lesions greater than 3 mm treated with the NirFlex bare metal coronary stent. The treatment arm showed late-loss rate of 0.65 mm in addition to target vessel revascularization rates of 4.4%, 7% and 8.9% at 180 days, 210 days and 280 days, respectively. Antonio Colombo, MD, San Raffaele Hospital, Milan, Italy, served as the study's principal investigator...